临床路径在无抽搐电休克治疗精神分裂症患者中的应用  

THE EFFECT OF CLINICAL PATHWAY USED FOR SCHIZOPHRENIC PATIENTS TREATED WITH MODIFIED ELECTROCONVULSIVE THERAPY

作　　者：刘宗凤[1] LIU Zong-feng(Linyi City Mental Health Center,Linyi 276000,China)

机构地区：[1]临沂市精神卫生中心,山东临沂276000

出　　处：《山东医学高等专科学校学报》2022年第6期401-403,共3页Journal of Shandong Medical College

摘　　要：目的 探讨行CET治疗精神分裂症的护理方法。方法 将80例精神分裂症患者随机分为两组,各40例。两组患者均采用CET治疗,参照组给予常规护理,研究组采用临床护理路径护理。治疗前后分别采用BPRS、NOSIE-30量表对患者进行测评,用自制调查表调查患者家属满意度。结果 研究组治疗后BPRS、NOSIE-30评分较治疗前比较改善程度均优于参照组(t=4.54~11.56,P<0.01);研究组患者家属满意度为97.5%,高于参照组的72.5%(χ^(2)=9.80,P=0.002)。结论 将临床路径应用于行CET治疗的精神分裂症患者,可以有效改善患者的临床症状,提高护理质量,提升家属满意度。Objective To explore the effect of clinical pathway used for schizophrenic patients treated with modified electroconvulsive therapy(MECT). Methods 80 schizophrenic patients were randomly divided into two groups, with 40 cases in each group. Both groups were treated with MECT, with the control group given routine care and the research group given clinical nursing path. BPRS and NOSIE-30 were used to evaluate patients’ symptoms before and after the treatments, and the self-designed questionnaires were used to survey the satisfaction of patients’ family members. Results The BPRS and NOSIE-30 scores showed better improvement in the research group after treatments than in the control group(t=4.54-11.56, P<0.01). The satisfaction of patients’ family members in the research group was 97.5%, higher than 72.5% in the control group(χ^(2)=9.80,P=0.002). Conclusion Applying clinical pathway to schizophrenic patients undergoing MECT can effectively improve clinical symptoms to obtain better nursing quality and can enhance the satisfaction of patients’ family members.

关 键 词：精神分裂症 无抽搐电休克治疗 临床路径 

分 类 号：R749.3[医药卫生—神经病学与精神病学]